Jasper Therapeutics, Inc.
JSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $40 | $49 | $72 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $4 | $4 |
| Total Curr. Assets | $55 | $43 | $53 | $76 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $3 | $4 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $46 | $58 | $80 |
| Liabilities | – | – | – | – |
| Payables | $9 | $8 | $3 | $4 |
| Short-Term Debt | $2 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $11 | $8 | $10 |
| Total Curr. Liab. | $21 | $21 | $12 | $15 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $25 | $2 | $2 | $2 |
| Total NC Liab. | $25 | $2 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $2 | $3 | $2 |
| Total Liabilities | $46 | $23 | $15 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$308 | -$289 | -$262 | -$241 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $319 | $312 | $304 | $303 |
| Total Equity | $12 | $24 | $42 | $62 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $57 | $46 | $58 | $80 |
| Net Debt | -$49 | -$37 | -$46 | -$70 |